TNF and inflammatory bowel disease: Currently, five anti-TNF therapeutics and additional biosimilars thereof are approved and successfully used to treat autoimmune diseases, including rheumatoid arthritis (RA), juvenile RA, inflammatory bowel disease, psoriasis, and ankylosing spondylitis (4).